Literature DB >> 17979153

VEGF in biological control.

Ellen C Breen1.   

Abstract

Vascular endothelial growth factor A (VEGF-A) belongs to a family of heparin binding growth factors that include VEGF-B, VEGF-C, VEGF-D, and placental-like growth factor (PLGF). First discovered for its ability to regulate vascular endothelial cell permeability, VEGF is a well-known angiogenic factor that is important for vascular development and maintenance in all mammalian organs. The development of molecular tools and pharmacological agents to selectively inhibit VEGF function and block angiogenesis and/or vascular permeability has led to great promise in the treatment of various cancers, macular degeneration, and wound healing. However, VEGF is also important in animals for the regulation of angiogenesis, stem cell and monocyte/macrophage recruitment, maintenance of kidney and lung barrier functions and neuroprotection. In addition to its role in regulating endothelial cell proliferation, migration, and cell survival, VEGF receptors are also located on many non-endothelial cells and act through autrocrine pathways to regulate cell survival and function. The following review will discuss the role of VEGF in physiological angiogenesis as well as its role in non-angiogenic processes that take place in adult organs. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17979153     DOI: 10.1002/jcb.21579

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  76 in total

1.  Differential effects of substrate modulus on human vascular endothelial, smooth muscle, and fibroblastic cells.

Authors:  Karyn G Robinson; Ting Nie; Aaron D Baldwin; Elaine C Yang; Kristi L Kiick; Robert E Akins
Journal:  J Biomed Mater Res A       Date:  2012-02-28       Impact factor: 4.396

Review 2.  The mammary gland vasculature revisited.

Authors:  Anne-Catherine Andres; Valentin Djonov
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-08-14       Impact factor: 2.673

3.  Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors.

Authors:  Yayun Liang; Cynthia Besch-Williford; Indira Benakanakere; Philip E Thorpe; Salman M Hyder
Journal:  Breast Cancer Res Treat       Date:  2010-03-27       Impact factor: 4.872

4.  VEGF/VEGFR-2 changes in frontal cortex, choroid plexus, and CSF after chronic obstructive hydrocephalus.

Authors:  Jun Yang; Stephen M Dombrowski; Abhishek Deshpande; Natalie Krajcir; Mark G Luciano
Journal:  J Neurol Sci       Date:  2010-09-15       Impact factor: 3.181

5.  Angio-adaptation in unloaded skeletal muscle: new insights into an early and muscle type-specific dynamic process.

Authors:  Emilie Roudier; Charlotte Gineste; Alexandra Wazna; Kooroush Dehghan; Dominique Desplanches; Olivier Birot
Journal:  J Physiol       Date:  2010-09-27       Impact factor: 5.182

6.  Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.

Authors:  Erich R Mackow; Elena E Gorbunova; Nadine A Dalrymple; Irina N Gavrilovskaya
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

Review 7.  The adaptation of the cerebral circulation to pregnancy: mechanisms and consequences.

Authors:  Marilyn J Cipolla
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-16       Impact factor: 6.200

Review 8.  Therapeutic Approaches to the Regulation of Wound Angiogenesis.

Authors:  Mateusz S Wietecha; Luisa A DiPietro
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-04       Impact factor: 4.730

9.  Altered hypoxia-inducible factor-1 alpha expression levels correlate with coronary vessel anomalies.

Authors:  Jamie Wikenheiser; Julie A Wolfram; Madhusudhana Gargesha; Ke Yang; Ganga Karunamuni; David L Wilson; Gregg L Semenza; Faton Agani; Steven A Fisher; Nicole Ward; Michiko Watanabe
Journal:  Dev Dyn       Date:  2009-10       Impact factor: 3.780

10.  Caveolin-1 promotes autoregulatory, Akt-mediated induction of cancer-promoting growth factors in prostate cancer cells.

Authors:  Likun Li; Chengzhen Ren; Guang Yang; Alexei A Goltsov; Ken-ichi Tabata; Timothy C Thompson
Journal:  Mol Cancer Res       Date:  2009-11-10       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.